a 135 (Trilipix 135 mg)
Generic Name: fenofibric acid
Pill imprint a 135 has been identified as Trilipix 135 mg.
Trilipix is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Trilipix 135 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- fenofibric acid
- Imprint:
- a 135
- Strength:
- 135 mg
- Color:
- Blue & Yellow
- Size:
- 22.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-9189
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00115-1460 | Global Pharmaceuticals |
| 68382-0078 | Zydus Pharmaceuticals (USA) Inc. |
| 54868-5986 | Physicians Total Care Inc (repackager) |
| 68258-6072 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More about Trilipix (fenofibric acid)
Consumer resources
- Other brands: Fibricor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
